Difference between revisions of "Epoetin alfa (Procrit)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m (Text replacement - "chemocare.com/chemotherapy/drug-info" to "chemocare.com/druginfo")
Line 9: Line 9:
 
*[http://www.procrit.com/shared/product/procrit/procrit-instructions-for-use.pdf Epoetin alfa (Procrit) patient instructions for use]<ref>[http://www.procrit.com/shared/product/procrit/procrit-instructions-for-use.pdf Epoetin alfa (Procrit) patient instructions for use]</ref><ref>[[:File:Epoetin instructions.pdf | Epoetin alfa (Procrit) patient instructions for use (locally hosted backup)]]</ref>
 
*[http://www.procrit.com/shared/product/procrit/procrit-instructions-for-use.pdf Epoetin alfa (Procrit) patient instructions for use]<ref>[http://www.procrit.com/shared/product/procrit/procrit-instructions-for-use.pdf Epoetin alfa (Procrit) patient instructions for use]</ref><ref>[[:File:Epoetin instructions.pdf | Epoetin alfa (Procrit) patient instructions for use (locally hosted backup)]]</ref>
 
*Brief patient counseling information can be found in [http://www.procrit.com/shared/product/procrit/procrit-prescribing-information.pdf the Epoetin alfa (Procrit) package insert]<ref name="insert"></ref>
 
*Brief patient counseling information can be found in [http://www.procrit.com/shared/product/procrit/procrit-prescribing-information.pdf the Epoetin alfa (Procrit) package insert]<ref name="insert"></ref>
*[https://chemocare.com/chemotherapy/drug-info/epoetin-alfa.aspx Epoetin alfa (Procrit) patient drug information (Chemocare)]<ref>[https://chemocare.com/chemotherapy/drug-info/epoetin-alfa.aspx Epoetin alfa (Procrit) patient drug information (Chemocare)]</ref>
+
*[https://chemocare.com/druginfo/epoetin-alfa.aspx Epoetin alfa (Procrit) patient drug information (Chemocare)]<ref>[https://chemocare.com/druginfo/epoetin-alfa.aspx Epoetin alfa (Procrit) patient drug information (Chemocare)]</ref>
 
*[http://www.uptodate.com/contents/epoetin-alfa-patient-drug-information Epoetin alfa (Procrit) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/epoetin-alfa-patient-drug-information Epoetin alfa (Procrit) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/epoetin-alfa-patient-drug-information Epoetin alfa (Procrit) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/epoetin-alfa-patient-drug-information Epoetin alfa (Procrit) patient drug information (UpToDate)]</ref>
  

Revision as of 23:32, 2 September 2023

General information

Class/mechanism: Erythropoiesis-stimulating agent (ESA), stimulates division and differentiation of erythroid precursors.[1][2][3][4]
Route: SC, IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

History of changes in FDA indication

  • 1989-06-01: Initial FDA approval

Also known as

  • Generic names: Erythropoetin, Erythropoietin
  • Brand names: Ceriton, Dynepo, Epoch, Epofer, Epogen, Epogin, Epoimmun, Epomax, Epopen, Epox, Epoyet, Eprex, Eritrelan, Erypo, Erythrostim, Espo, Globuren, Hemapo, Hemax, LG Espogen, Procrit, Recormon, Vepox, Vintor, Wepox

References